2009 Catecholamines Gordon Research Conference

描述（由申请人提供）：2009年戈登研究会议上的儿茶酚胺将于2009年8月在比德福德，ME。这个小型会议，每隔一年举行一次，是探索儿茶酚胺领域新发展的理想论坛。这也是初级调查员和受训人员在轻松的气氛中与资深调查员互动的绝佳机会。对最近会议的评估凸显了这次会议通常对新兴科学家产生的强烈影响。由于戈登会议组织分配的资金有限，我们正在请求其他来源提供资金。我们希望，我们的请求的结果使我们能够支持发言者和讨论领导人以及大量初级调查员参加会议。会议包括两次全体会议，由D。James Surmeier和Eric Nestler。初步计划包括大量的初级科学家和妇女，计划的会议包括：1）解剖组织的新观点; 2）儿茶酚胺和突触传递; 3）药理学：受体异二聚体; 4）奖励过程; 5）认知效应; 6）神经退行性疾病; 7）儿茶酚胺和精神障碍; 8）儿茶酚胺和药物成瘾，9）青春期，和10）转基因方法。公共卫生相关性：在2009年戈登会议上所涵盖的主题是高度相关的理解药物成瘾和各种神经和神经精神障碍，包括精神分裂症，情感障碍，双相情感障碍，强迫症，抽动秽语综合征和帕金森氏症的神经生物学基础。本次论坛将提供一个独特的机会，讨论在了解如何儿茶酚胺系统可能有助于这些条件的病理生理学和治疗的最新进展。很大一部分参与者是初级研究人员，相当一部分将是研究生和博士后，这一事实确保了这次会议可能会对未来几代神经科学家如何看待这些问题产生影响。

DESCRIPTION (provided by applicant): The 2009 Gordon Research Conference on Catecholamines will take place in Biddeford, ME on August 2009. This small conference, held every other year, is an ideal forum for exploring new developments in the field of catecholamines. It is also an excellent opportunity for junior investigators and trainees to interact with established investigators in a relaxed atmosphere. The evaluations of recent conferences highlight the strong impact this meeting typically has on emerging scientists. As the funds allocated by the Gordon Conference organization are limited, we are requesting funding from other sources. We are hoping that the results of our requests enable us to support speakers and discussion leaders as well as a large number of junior investigators to participate in the meeting. The conference includes two plenary talks, by D. James Surmeier and by Eric Nestler. The preliminary program includes a large number of junior scientists and women, and the sessions planned include: 1) Novel views on anatomical organization; 2) Catecholamines and synaptic transmission; 3) Pharmacology: receptor heterodimers; 4) Reward processes; 5) Cognitive effects; 6) Neurodegenerative diseases; 7) Catecholamines and mental disorders; 8) Catecholamines and drug addiction, 9) Adolescence, and 10) Transgenic approaches. PUBLIC HEALTH RELEVANCE: The themes covered in the 2009 Gordon Conference on Catecholamines are highly relevant to understanding the neurobiological bases of drug addiction and a variety of neurological and neuropsychiatric disorders including schizophrenia, affective disorders, bipolar disorder, OCD, Tourette's Syndrome and Parkinson's disease. This forum will provide a unique opportunity to discuss recent advances in the understanding of how catecholamine systems may contribute to the pathophysiology and treatment of those conditions. The facts that a large proportion of the participants are junior investigators and a significant number will be graduate students and postdocs ensure that this conference may have an impact on how future generations on neuroscientists view these issues.